Navasota Group announced today that Dr. Tamachi Saito has joined Navasota Group Board of Directors.
Dr. Saito graduated from Hitotsubashi University, majored in commerce and management. He has supported portfolio companies with hands-on IPO and investment development to venture companies. Dr. Saito assisted 22 companies for IPOs for 14 years.
In 2000, he developed a venture capital organization from scratch and was in charge of recruiting, team formation, a fund plan and operation management system. As Chief Investment Officer of investment committee, he was responsible for overall investment development. Dr. Saito received investment from the "public sector" and "pension fund," which are usually very strict about judicial responsibility and operated and managed total fund of 9.6 billion yen in limited partnership method. At the same time, invested 94 venture companies, among which are in the early stage.
He is currently a Director of a number of companies involved and is retained as an adviser by several Tokyo based investment organizations.
Dr. Conway, CEO at Navasota, stated, "Dr. Saito's extensive knowledge and experience in guiding companies through the IPO transition makes him an invaluable addition to Navasota Group’s Board of Directors."
About Navasota Group
Founded in 2003, Navasota Group (navasotagroup.com) specializes in; alternative energy, biotechnology, oil and gas technology, medical devices and instrumentation, imaging and diagnostics, nanotechnology firms, heavy industry technology, and mining operations. Navasota Group funds total more than $800 million.